Speak directly to the analyst to clarify any post sales queries you may have.
Squalene is a natural organic compound that primarily originates from shark liver oil and plant sources such as olive, rice, and bran oil and is also synthesized through the fermentation of yeast. It is a precursor to various sterols, including cholesterol, which plays a vital role in various biological functions within the human body. Increasing demand for natural and eco-friendly cosmetic products and growing awareness about skincare benefits associated with squalene are driving market growth. Rising advancements in biotechnology help to synthesize methods such as yeast fermentation, elevating the demand for squalene.
Furthermore, growing applications in pharmaceuticals as an adjuvant for vaccine formulations contribute significantly to market expansion. Stringent regulations on shark fishing for liver oil extraction and fluctuating raw material prices are hampering market growth. The growing development of cost-effective and eco-friendly technologies to produce high-purity squalene from alternative sources is expected to create opportunities for market growth.
Regional Insights
In the Americas, growing consumer awareness towards natural and sustainable products is driving demand for squalene in various industries such as cosmetics, pharmaceuticals, and food supplements. Continuous expansion of cosmetics and pharmaceuticals industries with rising usage of squalene within the European Union (EU) countries is expected to create opportunities for market growth.Additionally, the growing availability of stringent regulations on shark-derived squalene is influencing European market vendors to develop alternative sources. Booming cosmetic industries in China, Japan, and India driven by consumer trends favoring natural ingredients are creating a platform for the squalene market in Asia-Pacific. Further, the government recently increased funding for research programs related to bio-based materials, including squalene, thereby benefiting market growth.
Market Trends by Segment
- Raw Material: Growing adoption of biosynthetic squalene with rising environmental concerns
- Application: Growing application of squalene in cosmetic & personal care products owing to its moisturizing and emollient properties
Industry Insights
- Market Dynamics
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
- FPNV Positioning Matrix
- Market Share Analysis
- Strategy Analysis and Recommendations
Recent Developments
Croda International plc Partners on Vaccine Adjuvants
Croda International plc, a reputable UK-based specialty chemicals company, has recently formed partnerships with US companies Amyris and BSI to secure sustainable vaccine adjuvants. Under an exclusive license agreement with Amyris, Croda International plc would be able to source biotechnology-derived, pharmaceutical-grade squalene. Unlike traditional sources derived from shark liver, this squalene will be derived from sugarcane. Croda International plc would leverage its expertise in pharmaceutical good manufacturing practices (GMP) to market, distribute, and sell squalene as an excipient or in formulated products for human or veterinary vaccines, drug delivery systems, or nucleic acid delivery systems. This collaboration not only ensures the availability of high-quality squalene but also emphasizes the commitment to sustainability in the pharmaceutical industry.Evonik Launches Plant-based Squalene to Boost Vaccine Efficacy
Evonik AG introduced PhytoSquene, a non-animal-derived squalene specifically designed for vaccines and other pharmaceutical applications. This product is the first of its kind, derived from amaranth oil, and is now available on the market for use in adjuvants in parenteral dosage forms. This launch marks a significant milestone in the industry, offering a sustainable and ethical alternative to animal-derived squalene, which is traditionally sourced from shark liver oil. With the introduction of PhytoSquene, Evonik AG is taking a proactive approach towards achieving this goal. By utilizing this innovative solution, the industry can continue to meet its needs while minimizing its impact on the environment.Amyris Starts Squalene Production at Plant in Brazil
Amyris commenced industrial-scale production of 13 molecules, including squalene, at its plant in Brazil. Traditionally sourced from shark livers, squalene is used as an ingredient in skincare products and vaccine adjuvants. However, Amyris has developed a process to produce sugarcane-derived squalene as a sustainable alternative. The Barra Bonita facility boasts five self-contained lines for diverse molecule production, facilitating faster turnaround times and reducing the carbon footprint. This advancement enables quicker time to market and streamline the transition from pilot to manufacturing scale.Key Company Profiles
The report delves into recent significant developments in the Squalene Market, highlighting leading vendors and their innovative profiles. These include Amyris, Inc., Arbee Biomarine Extracts Private Limited, Arista Industries Inc., Blueline Foods India Pvt Ltd, Carbomer, Inc., Croda International Plc, Evonik Industries AG, Gracefruit Ltd., Kishimoto Special Liver Oil Co. Ltd., Maruha Nichiro Corporation, Maypro, New Zealand Green Health Ltd., Nucelis LLC, Oleicfat S.L., Otto Chemie Pvt. Ltd., SeaDragon Marine Oils Ltd., SOPHIM, and Vestan SA.This research report offers invaluable insights into various crucial aspects of the Squalene Market:
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
Companies Mentioned
- Amyris, Inc.
- Arbee Biomarine Extracts Private Limited
- Arista Industries Inc.
- Blueline Foods India Pvt Ltd
- Carbomer, Inc.
- Croda International Plc
- Evonik Industries AG
- Gracefruit Ltd.
- Kishimoto Special Liver Oil Co. Ltd.
- Maruha Nichiro Corporation
- Maypro
- New Zealand Green Health Ltd.
- Nucelis LLC
- Oleicfat S.L.
- Otto Chemie Pvt. Ltd.
- SeaDragon Marine Oils Ltd.
- SOPHIM
- Vestan SA
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 197 |
Published | May 2024 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 161.06 Million |
Forecasted Market Value ( USD | $ 249.33 Million |
Compound Annual Growth Rate | 7.5% |
Regions Covered | Global |
No. of Companies Mentioned | 18 |